Pan Li

机构：Xuzhou Medical College, Sichuan University, West China Hospital of Sichuan University, Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0002-6810-2367

发表论文 66 篇 · 总被引 1268 次 · h-index 15

代表论文

• Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy (2022 · Gastroenterology · 被引 78)
• Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway (2017 · Oncology Letters · 被引 63)
• A systematic analysis of immune genes and overall survival in cancer patients (2019 · BMC Cancer · 被引 50)
• Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation (2016 · Journal of the American Chemical Society · 被引 39)
• Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model (2022 · Cancer Letters · 被引 34)
• CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer (2023 · Gastroenterology · 被引 33)